Harvia Plc, Stock Exchange Release, September 8, 2025 at 2.30 PM EEST Composition of the shareholders’ nomination board of Harvia Plc Harvia Plc’s shareholders’ nomination board prepares proposals concerning the election and remuneration of the Board Members as well as the remuneration of the members of the various Board committees that will be submitted to future Annual General Meetings and to any Extraordinary General Meetings where necessary. The shareholders’ nomination board will be comprised of repres ...

TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) is pleased to provide an update on drilling and development activities at the Company’s Mercur Gold Project (“Mercur” or, the “Project”) located in Utah, U.S.A. Drilling Highlights Two rigs operating at Mercur since July have completed approximately 3,200 meters of a planned 13,000-meter drilling program at Mercur this year.Six PQ core holes have been drilled to collect material from the ...

Core Insights - Exodus Movement, Inc. is considering a potential quarterly Bitcoin dividend for shareholders, supported by an increase in its Bitcoin treasury [4] - As of August 31, 2025, Exodus holds 2,116 BTC, up from 2,087 BTC in July 2025, indicating operational strength [1] - The company reported a decrease in Monthly Active Users (MAUs) to 1.6 million in August 2025 from 1.7 million in July 2025 [2] - Exchange provider processed volume for August 2025 was $572 million, down from $632 million in July 2025, with a consistent contribution from XO Swap partners [3] Digital Asset Holdings - Bitcoin (BTC): 2,116 BTC as of August 31, 2025, compared to 2,087 BTC as of July 31, 2025 [1] - Ethereum (ETH): 2,756 ETH as of August 31, 2025, compared to 2,742 ETH as of July 31, 2025 [1] - Solana (SOL): 43,738 SOL as of August 31, 2025, compared to 34,578 SOL as of July 31, 2025 [1] User Metrics - Monthly Active Users (MAUs): 1.6 million as of August 31, 2025, down from 1.7 million in July 2025 [2] - Passkeys wallets: Approximately 11,000 as of August 31, 2025, compared to 20,000 in July 2025 [2] Exchange Volume - Processed volume for August 2025: $572 million, down from $632 million in July 2025 [3] - XO Swap partners contributed $149 million (26%) to the August volume, compared to $149 million (24%) in July [3]

Core Insights - Insight Molecular Diagnostics, Inc. (iMDx) announced a positive strategic update regarding its kidney transplant rejection assay and the establishment of a novel registry to collect real-world data on patient experiences and outcomes [1][2] Company Developments - The company plans to enroll 5,000 patients across at least 25 centers over three years, aiming to support the clinical utility of its unique assay and an accelerated monitoring protocol for high-risk patients [2][3] - CEO Josh Riggs highlighted the significance of the registry as a supportive data repository and expressed optimism about centers transitioning to in-house testing post-regulatory clearance [3] - CFO Andrea James emphasized the alignment of the registry rollout with the company's growth strategy and revenue generation plans at its Nashville lab [3] Industry Context - The registry announcement follows key developments, including claims expansion for dd-cfDNA testing in CLIA certified labs and an increased reimbursement rate for GraftAssureCore to $2,753 per result by CMS [3][4] - Late-breaking data presented at the World Transplant Congress indicated improved positive predictive value (PPV) for graft rejection, leading to fewer false positives and reduced invasive biopsies [3][4] Technological Innovations - iMDx has introduced two critical clinical innovations: the Berlin Protocol for testing frequency in high-risk patients and an algorithmic approach to enhance biopsy yields [4][6] - The company aims to deliver a best-in-class molecular diagnostic test kit, targeting an estimated $1 billion addressable market for transplant rejection testing [4][6] Product Overview - iMDx's flagship technology quantifies donor-derived cell-free DNA (dd-cfDNA), a biomarker for transplant rejection, and is commercialized under the GraftAssure™ brand [7][8] - The GraftAssureCore test is currently reimbursed by CMS and performed at the company's CLIA-certified laboratory in Nashville, with plans to rebrand the VitaGraft assay under this name [11]

Core Insights - Bitcoin Bancorp has been retained by Sadot Group Inc. to design and implement a comprehensive Bitcoin treasury strategy, marking a significant step for Sadot as one of the first NASDAQ-listed companies in the agricultural sector to explore Bitcoin as a treasury reserve asset [1][2]. Group 1: Strategic Engagement - The collaboration aims to develop a treasury framework that prioritizes governance, security, and liquidity, reflecting a cautious and policy-driven approach to integrating Bitcoin into Sadot's treasury operations [3][4]. - Sadot's CEO highlighted Bitcoin's fixed supply and growing adoption by global corporations as attractive features for a treasury reserve asset [3]. Group 2: Corporate Bitcoin Treasury Adoption - Sadot joins a growing list of public companies adopting Bitcoin as part of their corporate treasury strategy, despite tightening regulatory oversight [4]. - Other notable companies, such as MicroStrategy and GameStop, have also made significant Bitcoin purchases as part of their treasury policies, indicating a broader trend in corporate adoption of Bitcoin [7]. Group 3: Treasury Policy Framework - The treasury strategy will align with FASB ASU 2023-08 fair-value accounting standards and include institutional-grade custody solutions, risk-managed acquisition models, and ongoing treasury operations to ensure compliance with SEC and NASDAQ requirements [6]. Group 4: Company Overview - Sadot Group Inc. is a global food supply chain company that sources and distributes agri-commodities from various regions to markets in Southeast Asia, China, and the Middle East/North Africa, emphasizing innovation, transparency, and sustainability [5]. - Bitcoin Bancorp specializes in blockchain technologies and digital asset management, aiming to drive innovations in digital and blockchain-related platforms [8].

ANN ARBOR, Mich., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, is happy to announce the appointment of Mr. Kenneth Le as Managing Director of its wholly owned recombinant spider silk production subsidiary, Prodigy Silk Ltd. Le has been an integral leader in the Company’s Southeast Asian operations for many years, overseeing the expansion of its specialized spider silk rearing and production systems ...

Extension of forbearance period to September 30, 2025 MONTREAL, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Dorel Industries Inc. (TSX: DII.B, DII.A) announced today that the previously-announced forbearance period under its asset backed loan (ABL) facility and term loan facility has been extended by Dorel’s lenders to the earlier of September 30, 2025 (from September 16, 2025) and the occurrence of any event of default, other than the previous event of default, under the ABL facility. Also as previously announced, ...

NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (“Prospect”) (NASDAQ: PSEC) and an affiliate have provided a first lien senior secured term loan, a first lien senior secured revolving credit facility, and an equity investment to TCSPV Holdings IV, LLC (“The Ridge” or “Company”), aggregating approximately $18 million, in collaboration with Thesis Capital Partners. The Ridge is a physician-led addiction treatment facility that delivers personalized care in a luxurious residential set ...

-- Recommendation that trial escalate to next dose level of 8mg tablet -- -- Initial interim clinical data from first two cohorts expected in Q1 2026 -- MIAMI, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor today announced that the external Safety Review Committee recommended that the Company’s Phase 1/1b open label study to assess the safety, t ...

TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Talisker Resources Ltd. (“Talisker” or the “Company”) (TSX: TSK, OTCQX: TSKFF) is pleased to announce the successful completion of its first gold sale from its 100% owned Bralorne Gold Project in British Columbia (“Bralorne”). The Company sold 707 ounces of gold in August, generating gross proceeds of approximately US$2.3 million. This first gold sale marks a key milestone for Talisker, confirming its shift from an advanced-stage developer to an active gold produc ...